CoChat

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Objective To determine the epidemiological and clinical significance of invasive fungal infections in non-neutropenic patients in intensive care who stay longer than 10 days on the intensive care unit (ICU).Design Prospective epidemiological multicenter study over a period of 11 months, based on strict clinical, bacteriological, serological and histological criteria.Setting Six surgical and two medical ICUs units in five university and two municipal hospitals.Patients 435 non-neutropenic patients from medical and surgical ICUs with an ICU stay of more than 10 days.Measurements and main results A new occurrence of invasive mycosis (3 sepsis/4 peritonitis/1 disseminated candidiasis), corresponding to the protocol conditions with onset after day 10 in the ICU, was detectable in 2.0% (95% confidence interval 0.85 to 3.8%) of the 409 patients who could be assessed. Candida species were identified as an infection-relevant pathogen in all cases. The most important risk factor for the development of an invasive mycosis was the onset of peritonitis by the day 11 in the ICU (odds ratio 11.3; p = 0.003). A fungal colonization was detected in 64% of patients (Candida species 56%, Aspergillus 4%, and other fungi). Six of 8 patients with an invasive mycosis died on the ICU; ICU mortality in patients with fungal colonization was 31% and in noncolonized patients 26%. Serological tests were not helpful clinically. The sensitivity was 88% for the Candida HAT (haemagglutination test) (threshold titer > 1:160), 100% for the Candida IFT (immunofluorescence test) (threshold titer > 1:80), and 50% for the Candida Antigen Test (Candtec Ramco, threshold titer > or = 1:8), and the specificity was 26, 6, and 73%, respectively. The specificity for the Aspergillus HAT (threshold titer > 1:10) was 29%.Conclusions Invasive mycoses are rare in non-neutropenic ICU patients, even after a longer stay in the intensive care unit; fungal colonization, on the other hand, is frequently detectable. The mortality of invasive mycosis--even with systemic antimycotic therapy--was high; the mortality in patients with fungal colonization was not significantly increased compared to that in noncolonized patients. The serological test procedures, Candida HAT, Candida IFT, and the Candida Ramco Antigen Test, had a low specificity and were not helpful in diagnosing relevant invasive mycosis.

Overview

Integrity signals

Registry

Crossref · 10.1007/s001340050334

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Cited by

Items 101–200 of 200

Metadata

Authors
Petri, M. G., König, J., Moecke, H. P., Gramm, H. J., Barkow, H., Kujath, P., Dennhart, R., Schäfer, H., Meyer, N., Kalmar, P., Thülig, P., Müller, J., & Lode, H.
Affiliations
  • Freie Universität Berlin (DE)
  • Heidelberg University (DE)
  • Asklepios Klinik Altona (DE)
  • Universitätsklinikum Würzburg (DE)
  • Krankenhaus Nordwest (DE)
  • Universitätsklinik Marien Hospital Herne (DE)
  • University Medical Center Hamburg-Eppendorf (DE)
  • University Hospital Münster (DE)
  • University of Freiburg (DE)
Venue
Intensive Care Medicine
Published
1997-03-12
Volume
23
Issue
3
Pages
317-325
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W2021610658
Cited by
185
References
31
Citations by year
2026: 1 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 2 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 5 · 2013: 2 · 2012: 2
FWCI
2.62
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Intensive Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
invasive mycosis, invasive fungal infections, non-neutropenic patients, intensive care unit, Candida, peritonitis, fungal colonization, risk factors, mortality, serological diagnosis, Aspergillus, sepsis, systemic candidiasis, ICU length of stay, epidemiology, sensitivity and specificity, histopathology, immunofluorescence
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Female, Germany, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Mycoses, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Chi-Square Distribution, Logistic Models, Hospital Mortality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.